Presence of five conditioning film proteins are highly associated with early stent encrustation.
OBJECTIVE
Ureteral stents are susceptible to biofilm formation and crystal deposition, especially in stone formers. To identify proteins responsible for this accumulation, we compared conditioning film proteomes obtained from human ureteral stents with and without encrustation.


METHODS
Twenty-seven Bard Inlay hydrophilic ureteral stents were removed after ureteroscopy. Stent encrustation was quantified by visual analog score 0 (none) to 4 (heavy) and further categorized as nonencrusted (scores 0 and 1; n = 22) or encrusted (scores 2, 3, and 4; n = 5). Stent conditioning film was sampled and digested with trypsin, and peptide tandem mass spectrometry data were acquired using liquid chromatography. After protein identification, unconditional exact tests were used to compare categorical variables versus encrustation outcome. Stone analysis and follow-up metabolic urine profiles were examined to identify additional risk factors for stent encrustation.


RESULTS
More than 300 unique proteins with >95% confidence were identified. Proteins alpha-1 anti-trypsin, Ig kappa, IgH G1, and histone H2b and H3a were found to be highly associated with stent encrustation (p < 0.05), while Tamm-Horsfall protein and histone H2a were found to have a marginal association (p < 0.1). Patients with early stent encrustation were more likely to have mixed stone analysis (p = 0.03) and low urinary volumes (p < 0.01).


CONCLUSIONS
Immunoglobulins and Tamm-Horsfall protein are common urinary proteins that appear to nonselectively bind early onto ureteral stent surfaces. Histones, nuclear DNA-condensing proteins, likely contribute to stent encrustation because of their unique net positive charge and may represent a potential clinical target for encrustation prevention.
Canales
Benjamin K
BK
Department of Urology, University of Florida, Gainesville, Florida, USA. benjamin.canales@urology.ufl.edu
Higgins
LeeAnn
L
Markowski
Todd
T
Anderson
Lorraine
L
Li
Qin A
QA
Monga
Manoj
M
D003710:Demography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000032:analysis*; D015607:Stents / Q000009:adverse effects*; D014545:Urinary Calculi / Q000473:pathology
D011506:Proteins
J Appl Physiol (1985). 2005 Jan;98(1):257-63
15286052
J Endourol. 2008 Jun;22(6):1161-7
18484873
Kidney Int. 1993 Aug;44(2):423-9
8397318
Science. 1987 Sep 18;237(4821):1479-84
3498215
J Clin Invest. 1997 Feb 15;99(4):732-6
9045877
Nat Clin Pract Urol. 2004 Nov;1(1):44-8
16474466
Eur Urol. 1999;36(1):53-9
10364656
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11207-10
12966187
J Endourol. 2006 Jan;20(1):64-8
16426136
Biochemistry. 2003 Dec 30;42(51):15310-25
14690441
Biomaterials. 1999 Jul;20(13):1245-51
10395394
Science. 1987 Sep 25;237(4822):1588-95
3629258
BJU Int. 2000 Nov;86(8):935-41
11069430
Urology. 2001 Oct;58(4):526-31
11597531
Cell. 1990 Nov 2;63(3):631-42
2171779
Nat Genet. 2000 May;25(1):25-9
10802651
J Biomed Mater Res A. 2005 Sep 15;74(4):722-38
16037938
Blood. 2001 Aug 15;98(4):1231-8
11493475
Br J Urol. 1994 Jun;73(6):687-91
8032837
Biotechniques. 2004 Jun;36(6):917-9
15211739
J Mater Sci Mater Med. 2008 May;19(5):2179-85
18044011
J Am Chem Soc. 2003 Oct 22;125(42):12782-6
14558825
Biomaterials. 2002 Dec;23(23):4601-8
12322981